Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

PHASE3TerminatedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

May 5, 2022

Primary Completion Date

May 18, 2023

Study Completion Date

May 18, 2023

Conditions
Temporomandibular Disorders (TMD)
Interventions
DRUG

Rimegepant

75 mg ODT

DRUG

Placebo

matching placebo

Trial Locations (32)

11725

North Suffolk Neurology, Commack

14618

University of Rochester, Rochester

15201

University of Pittsburgh, Pittsburgh

19104

Perelman Center for Advanced Medicine, Philadelphia

27617

Duke University, Raleigh

33021

The Medici Medical Research, LLC, Hollywood

The Medici Medical Research, Hollywood

33136

SouthCoast Research Center, Inc, Miami

SouthCoast Research Center, Miami

33144

Oceane7 Medical & Research Center, Inc., Miami

33607

Florida Craniofacial Institute, Tampa

33613

Forcare Clinical Research, Tampa

40536

University of Kentucky, College of Dentistry, Lexington

45066

Kulkarni Orthodonties, Springboro

45432

META Medical Research Institute,LLC., Dayton

Meta Medical Research, Dayton

46202

Campus Health, Indiana University-Purdue University Indianapolis, Indianapolis

IDS-IU Simon Cancer Center (IUSCC), Indianapolis

Indiana University School of Dentistry, Indianapolis

55455

TMD, Orofacial Pain and Dental Sleep Medicine Clinic, School of Dentistry, University of Minnesota, Minneapolis

University of Minnesota, Minneapolis

65807

Clinvest Research, LLC, Springfield

65810

Clinvest Research, Springfield

76550

FMC Science, Lampasas

77566

Red Star Research, LLC, Lake Jackson

Red Star Research, Lake Jackson

84107

JBR Clinical Research, Salt Lake City

JBR, Salt Lake City

85020

Bruce Nelson, DDS, Phoenix

85053

Arizona Research Center, Phoenix

98007

Northwest Clinical Research Center, Bellevue

98121

Snoring and Sleep Apnea Center (DC/TMD Exam - Dr. Christian), Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY